These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26399862)

  • 21. Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology.
    Na DG; Kim JH; Sung JY; Baek JH; Jung KC; Lee H; Yoo H
    Thyroid; 2012 May; 22(5):468-75. PubMed ID: 22304417
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic markers differentiating follicular thyroid carcinoma from benign lesions.
    Freitas BC; Cerutti JM
    Mol Cell Endocrinol; 2010 May; 321(1):77-85. PubMed ID: 19932149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New technology in thyroid fine-needle aspiration.
    Poller DN
    J Clin Pathol; 2014 Jun; 67(6):457. PubMed ID: 24695840
    [No Abstract]   [Full Text] [Related]  

  • 25. Contemporary diagnostic approach to the thyroid nodule.
    Rosen JE; Stone MD
    J Surg Oncol; 2006 Dec; 94(8):649-61. PubMed ID: 17131409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling Hürthle cell lesions of the thyroid using molecular findings.
    Wong KS
    Cancer Cytopathol; 2022 Jun; 130(6):405-406. PubMed ID: 35285577
    [No Abstract]   [Full Text] [Related]  

  • 27. Re: The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm.
    Kuru B
    Surgery; 2008 Jun; 143(6):835-6. PubMed ID: 18549905
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area.
    Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of the genetics of thyroid tumours: diagnostic and prognostic implications.
    Gilfillan CP
    ANZ J Surg; 2010 Jan; 80(1-2):33-40. PubMed ID: 20575878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
    Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
    Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DIAGNOSIS OF ENDOCRINE DISEASE: Usefulness of genetic testing of fine-needle aspirations for diagnosis of thyroid cancer.
    Stewardson P; Eszlinger M; Paschke R
    Eur J Endocrinol; 2022 Sep; 187(3):R41-R52. PubMed ID: 35900312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Putting an eye on cytological specimens: an audit of the clinical impact of thyroid fine-needle aspiration in different health care settings.
    Pereira BD; Gerhard R; Schmitt F
    Diagn Cytopathol; 2014 Dec; 42(12):1009-12. PubMed ID: 24678022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular fine-needle aspiration biopsy diagnosis of thyroid nodules by tumor specific mutations and gene expression patterns.
    Eszlinger M; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):29-37. PubMed ID: 20083161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnostic value of BRAFV600E and RET/PTC oncogenes in thyroid nodule aspirates].
    Guerra A; Carrano M; Angrisani E; Vitale M
    Recenti Prog Med; 2013; 104(7-8):415-9. PubMed ID: 24042420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual priming oligonucleotide-based multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutation-prevalent area.
    Kwak JY; Kim EK; Kim JK; Han JH; Hong SW; Park TS; Choi JR
    Head Neck; 2010 Apr; 32(4):490-8. PubMed ID: 19672964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Search for genetic mutations in cytological samples from thyroid nodules as a diagnostic tool: reality, hope or myth?
    Pacini F; Cantara S; Capezzone M
    J Endocrinol Invest; 2010 Sep; 33(8):576-8. PubMed ID: 20930496
    [No Abstract]   [Full Text] [Related]  

  • 38. Utility of the ThinPrep technique in thyroid fine needle aspiration: optimal vs. practical approaches.
    Nasuti JF
    Acta Cytol; 2006; 50(1):3-4. PubMed ID: 16514833
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH; Baek JH; Lee JH; Choi YJ; Song DE; Chung KW; Kim TY; Shong YK
    Thyroid; 2015 Aug; 25(8):897-903. PubMed ID: 25978151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of genetic markers in the evaluation and management of thyroid nodules.
    Parangi S; Suh H
    Surg Clin North Am; 2014 Jun; 94(3):515-28. PubMed ID: 24857574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.